ANG Amtomen Biotech
Biotech company (website pending launch).
Company Overview
Snapshot
Founded in January 2025, ANG Amtomen Biotech operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on research and development within the biotechnology sector.
Business overview
ANG Amtomen Biotech is an Israeli company operating in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology, with a focus on Drugs Discovery & Development. The company's core activities are centered around biotechnology, though specific product or technology details are not yet publicly available as its website is pending launch. It primarily serves other businesses (B2B) and is currently in the R&D phase of its product development.
Log in to access full profile ›Company Intelligence Q&A
- When was ANG Amtomen Biotech founded?
- ANG Amtomen Biotech was founded in January 2025.
- What is ANG Amtomen Biotech's primary sector?
- ANG Amtomen Biotech operates primarily in the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the current employee count for ANG Amtomen Biotech?
- ANG Amtomen Biotech currently has 1–10 employees.
- Where is ANG Amtomen Biotech headquartered?
- ANG Amtomen Biotech is registered in Jerusalem, Israel, with an address at 36 Ma'alot, City of David.